MAY 2019

DAYSPA is the business resource for spa & wellness professionals! Each issue covers the latest in skin care, spa treatments, wellness services and management strategies.

Issue link:

Contents of this Issue


Page 65 of 76

May 2019 • 63 © GETTY IMAGES MAY 19-22 SPATEC Fall North America Miami JUNE 1-3 Premiere Orlando & Premiere DAYSPA JUNE 15-17 International Beauty Show (IBS) Las Vegas JUNE 15-17 International Esthetics, Cosmetics & Spa Conference (IECSC) Las Vegas DATE BOOK Make a note of these upcoming industr y events! BREAKOUT STAR Research presented at the American Academy of Dermatology (AAD) 2019 Annual Meeting in March revealed that Sebacia Microparticles result in 85 percent improvement in facial acne at 12 months. The treatment was cleared in 2018 by the U.S. Food and Drug Administration (FDA) for use as an accessory to 1064nm lasers to facilitate photothermal heating of sebaceous glands for the treatment of mild-to- moderate infl ammatory acne vulgaris. In the study, patients were prescribed a two- to four-week course of topical retinoid + benzoyl peroxide (BPO) followed by three weekly in-offi ce treatments of Sebacia Microparticles. After stopping treatment, patients were guided to clinical success with the help of their physicians, including reintroducing acne medications if desired. The fi ndings demonstrated a signifi cant effect on long- term acne outcomes, as well as a decreased need for medication. "Sebacia Microparticles represent an innovative new in-offi ce treatment for patients with mild-to-moderate acne, especially as it may help avoid progression to second- and third-line treatments, including systemic acne medications," says Jill S. Waibel, MD, founder of the Miami Dermatology and Laser Institute and a Sebacia U.S. clinical trial investigator.

Articles in this issue

Links on this page

Archives of this issue

view archives of Dayspa - MAY 2019